Division of Hematology/Oncology
Welcome to the Division of Hematology/Oncology
The Hematology/Oncology Division is devoted to patient care through clinical activity at the Medical University, Hollings Cancer Center, and at the affiliated Ralph H. Johnson VA Medical Center. Founded in 1993 and named for former US Senator and South Carolina Governor Ernest "Fritz" Hollings, the Hollings Cancer Center is the largest academic cancer center in South Carolina. It is the state's only National Cancer Institute (NCI)-designated cancer center and one of only 66 NCI centers in the U.S. Additionally, faculty members practice at the MUSC Health East Cooper facility in Mount Pleasant and the Specialty Care facility in North Charleston.
In conjunction with the Hollings Cancer Center (HCC), and the Ralph H. Johnson VA Medical Center, the Division serves as a statewide referral center for solid tumor oncology, benign and malignant hematology and bone marrow transplant. Our Blood and Marrow Transplant (BMT) Program was not only the first established in South Carolina but also the state’s only National Marrow Donor Program certified unrelated-donors program . It is the only pediatric and cord blood transplant program and considered a pioneer in outpatient bone marrow transplants. Furthermore, multidisciplinary clinics at the HCC allow patients with certain malignancies to see all of their physicians in one appointment. Clinics include breast, thoracic, neuro-oncology and head/neck cancer.
Following our ongoing commitment to research, our Faculty members serve as principal investigators on a multitude of laboratory and clinical projects while persistently pursuing new opportunities to fund their efforts. Through research, Dr. Harry Drabkin, Division Director, has made major contributions to our understanding of the pathogenesis of leukemia, kidney cancer and lung cancer. He is recognized in the treatment of metastatic kidney cancer and is active in clinical trials for this disease. Concurrently, the Division is developing the next generation of hematologists and oncologists with a fully accredited Fellowship Program who are encouraged to engage in this important work as well.